Cannabis Use During Lactation: Evidence-Based and Parent Centred Care
Cannabis is the most consumed psychoactive drug, with global estimated use approaching 200,000 million people. Legalization in different countries, together with apparent safety perception, has led to increased cannabis use by up to 5% of pregnant and breastfeeding women. This presents significant challenges for health professionals who promote breastfeeding. As central nervous system drugs need to be sufficiently lipophilic to pass the blood brain barrier, there will be extensive cannabis passage into lipophilic breast milk. Pre- and post-natal exposure is likely to impact not only on the mother but may also induce neurobiological alterations in the infant that persist beyond the first 1000 days of life. This presentation will take an evidence-based approach to outline the pharmacology, potential benefits, and risks of the main cannabinoids (THC and CBD) used in their various dose forms (ingested oils, topical gels or inhalation of buds by pipe or vaporizer). It will focus on the available evidence, potential consequences, and considerations when cannabis is used in lactation. Regardless of personal opinion, it is imperative that women feel comfortable to ask questions of their primary health care professionals about cannabis use or misuse while breastfeeding, to promote harm minimization.
This lecture was originally offered as part of the GOLD Lactation Conference 2023.
Treasure McGuire,
PhD, BSc, BPharm, GradDipClinHospPharm Adv Prac Pharm, GCHEd, CertIVTAE, FACP, FPS
Associate Professor Treasure McGuire is a clinical pharmacist, educator, and researcher. She holds two senior appointments in her hospital role (as Assistant Director of Pharmacy, Practice and Development, Mater Health Brisbane) with 1) Bond University Medical School (as Associate Professor of Pharmacology and 2) The University of Queensland School of Pharmacy (as Associate Professor, Clinical). She is passionate about improving the consumer voice and health outcomes for mothers and babies through the development and access to more effective and safer approaches towards medicines use.
Treasure’s research is translational and evidence-based, focusing on patient centred-care and quality use of medicines in women’s and newborn health, medicines information, medication safety and complementary medicines. She has published widely and authored the chapter on Safe use of drugs while breastfeeding In Brodribb W, ed. Breastfeeding management in Australia, 5th ed, Melbourne: Australian Breastfeeding Association, 2019. She is a regular invited speaker at national and international conferences, with over 60 keynote addresses. In recognition of her services to medicines information, she received the Lilly International Fellowship in Hospital Pharmacy. In 2015, she was the recipient of the Sr Eileen Pollard Medal (Mater Research-UQ) for excellence in incorporating research into clinical care provision.
Objective 1: Describe the pharmacology, ways cannabis is used therapeutically and as a recreational drug by breastfeeding mothers and its transfer into breast milk
Objective 2: Explain safety and practical considerations for cannabis use in breastfeeding
Objective 3: Describe realistic goals and strategies around harm minimisation.
Treasure McGuire,
PhD, BSc, BPharm, GradDipClinHospPharm Adv Prac Pharm, GCHEd, CertIVTAE, FACP, FPS
Cannabis is the most consumed psychoactive drug, with global estimated use approaching 200,000 million people. Legalization in different countries, together with apparent safety perception, has led to increased cannabis use by up to 5% of pregnant and breastfeeding women. This presents significant challenges for health professionals who promote breastfeeding. As central nervous system drugs need to be sufficiently lipophilic to pass the blood brain barrier, there will be extensive cannabis passage into lipophilic breast milk. Pre- and post-natal exposure is likely to impact not only on the mother but may also induce neurobiological alterations in the infant that persist beyond the first 1000 days of life. This presentation will take an evidence-based approach to outline the pharmacology, potential benefits, and risks of the main cannabinoids (THC and CBD) used in their various dose forms (ingested oils, topical gels or inhalation of buds by pipe or vaporizer). It will focus on the available evidence, potential consequences, and considerations when cannabis is used in lactation. Regardless of personal opinion, it is imperative that women feel comfortable to ask questions of their primary health care professionals about cannabis use or misuse while breastfeeding, to promote harm minimization.
Accreditation
CERPs - Continuing Education Recognition Points
Applicable to IBCLC Lactation Consultants, Certified Lactation Consultants (CLCs), CBEs, CLE, Doulas & Birth Educators. GOLD Conferences has been designated as a Long Term Provider of CERPs by IBLCE--Approval #CLT114-07. This program is approved for 1 L-CERP.
Dietetic CPEUs - Continuing Professional Education Units
Applicable to Dieticians & Nutritionists, this program is approved for 1 Dietetic CPEU by the Commission on Dietetic Registration - the credentialing agency for the Academy of Nutrition and Dietetics.
Midwifery CEUs - MEAC / NARM Contact Hours
This program is accredited through the Midwifery Education & Accreditation Council (MEAC) for 1 Contact Hour (0.1 MEAC CEU).
It is also recognized by the North American Registry of Midwives (NARM) for 1 CEU/Contact Hour. Please note that 0.1 MEAC CEU is equivalent to 1.0 NARM CEU/Contact Hour.
Nurse Contact Hours
This nursing continuing professional development activity was approved by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation for 1 Nursing Contact Hour.
- View this presentation in its entirety, under your individual GOLD login info
- Successfully complete a post-test (3 out of 3 questions correctly answered)
- Fill out the Evaluation Survey
If you have already participated in this program, you are not eligible to receive additional credits for viewing it again. Please email [email protected] if you have any questions.
Additional Details
Viewing Time: 2 Weeks
Tags / Categories
How much time do I have to view the presentations?
- The viewing time will be specified for each product. When you purchase multiple items in your cart, the viewing time becomes CUMULATIVE. Ex. Lecture 1= 2 weeks and Lecture Pack 2 = 4 Weeks, you will have a total of 6 weeks viewing time for ALL the presentations made in that purchase.
- Time for viewing the talks begins once you purchase the product. For Live Webinars & Symposiums, the viewing period begins from when the live event takes place. Presentations can be accessed 24/7 and can be viewed as many times as you like during the viewing period.
What are bundled lectures?
- Presentations may be available individually or via a bundled package. Bundled lectures are a set of lectures that have been put together based on a specific category or topic. Some lectures will be available in both individual and lecture form, whereas others will be available only via a bundled lecture pack.
Will there be Handouts?
- YES! Each lecture comes with a PDF handout provided by the Speaker.
Some lectures include a Q&A, what does that mean?
- During our online conferences, presentations that occur live are also followed by a short 15 minute Question & Answer Session. The Speaker addresses questions that were posted by Delegates during the presentation. We include the recording of these Q&A Sessions as a bonus for you.
How can I receive a Certificate?
- If this presentation offers a certificate, once you are done viewing the lecture or the lectures within a bundle, submit your attendance record in order to be able to download your certificate. You'll be able to see which credits are offered for the lecture by hovering over the "Credits Available" link within the "Speakers & Topics" tab.
Professionals that selected this package also viewed
|
|
|
